EVALUATION OF GLUCOSE HOMEOSTASIS IN TRANSFUSION-DEPENDENT THALASSEMIC PATIENTS

被引:4
|
作者
Siklar, Zeynep [1 ]
Citak, Funda Erkasar [2 ]
Uysal, Zuemruet [2 ]
Ocal, Gonul [1 ]
Ertem, Mehmet [2 ]
Engiz, Oezlem [1 ]
Adiyaman, Pelin [1 ]
ILeri, Talia [2 ]
Gozdasoglu, Sevgi [2 ]
Berberoglu, Merih [1 ]
机构
[1] Ankara Univ, Sch Med, Dept Pediat Endocrinol, TR-06100 Ankara, Turkey
[2] Ankara Univ, Sch Med, Dept Pediat Haematol, TR-06100 Ankara, Turkey
关键词
diabetes; FPIR; glucose metabolism; insulin resistance; thalassemia major;
D O I
10.1080/08880010802313681
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diabetes is an important problem encountered in thalassemic patients. The severity and type of glucose disturbances vary greatly in different studies. Also the pathogenesis seems to be complex; either insulin deficiency or insulin resistance may mediate the glucose disturbances. In a group of thalassemic patients glucose homeostasis was evaluated. Diabetes prevalence was 1.8%. Forty patients were investigated both with an oral glucose tolerance test and first-phase insulin response. Three patients had impaired fasting glucose, 1 patient had impaired glucose tolerance, and 2 patients had hyperinsulinism. Nineteen of 40 patients who were tested had low first-phase insulin response (47.5%) with below 10th centile. Age, BMI, height SDS, age at diagnosis, age at first blood transfusion, number of blood transfusions in a year, percentage of elevated liver enzyme, and hemoglobin and ferritin levels were not different between patients with low first-phase insulin response to patients with normal first-phase insulin response. Four patients are HCV infected, and only 1 of them had low first-phase insulin response. The study group showed a high rate of impairement in insulin secretion by first-phase insulin response to glucose overload, despite the low rate of insulin resistance. Defect of insulin secretion in thalassemic patients may develop earlier than insulin resistance, and then be accompanied by insulin resistance. Increasing insulin resistance with age and the occurrence of additional factors could lead to detoriation of glucose metabolism.
引用
收藏
页码:630 / 637
页数:8
相关论文
共 50 条
  • [21] Hypoparathyroidism in transfusion-dependent patients with β-thalassemia
    Nicholas G. Angelopoulos
    Anastasia Goula
    Grigorios Rombopoulos
    Victoria Kaltzidou
    Eugenia Katounda
    Dimitrios Kaltsas
    George Tolis
    Journal of Bone and Mineral Metabolism, 2006, 24 : 138 - 145
  • [22] Pharmacokinetics, Metabolism, and Disposition of Deferasirox in β-Thalassemic Patients with Transfusion-Dependent Iron Overload Who Are at Pharmacokinetic Steady State
    Waldmeier, Felix
    Bruin, Gerard J.
    Glaenzel, Ulrike
    Hazell, Katharine
    Sechaud, Romain
    Warrington, Steve
    Porter, John B.
    DRUG METABOLISM AND DISPOSITION, 2010, 38 (05) : 808 - 816
  • [23] Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon α-2b and ribavirin
    Sherker, AH
    Senosier, M
    Kermack, D
    HEPATOLOGY, 2003, 37 (01) : 223 - 223
  • [24] Liver steatosis in patients with transfusion-dependent thalassaemia
    Ricchi, Paolo
    Pistoia, Laura
    Positano, Vincenzo
    Spasiano, Anna
    Casini, Tommaso
    Putti, Maria Caterina
    Borsellino, Zelia
    Cossu, Antonella
    Messina, Giuseppe
    Keilberg, Petra
    Fatigati, Carmina
    Costantini, Silvia
    Renne, Stefania
    Peritore, Giuseppe
    Cademartiri, Filippo
    Meloni, Antonella
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (06) : 2458 - 2467
  • [25] Patients experience of being blood transfusion-dependent
    Ryblom, H.
    Hast, R.
    Hellstrom-Lindberg, E.
    Johansson, E.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S399 - S399
  • [26] Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
    Thompson, A. A.
    Walters, M. C.
    Kwiatkowski, J.
    Rasko, J. E. J.
    Ribeil, J. -A.
    Hongeng, S.
    Magrin, E.
    Schiller, G. J.
    Payen, E.
    Semeraro, M.
    Moshous, D.
    Lefrere, F.
    Puy, H.
    Bourget, P.
    Magnani, A.
    Caccavelli, L.
    Diana, J. -S.
    Suarez, F.
    Monpoux, F.
    Brousse, V.
    Poirot, C.
    Brouzes, C.
    Meritet, J. -F.
    Pondarre, C.
    Beuzard, Y.
    Chretien, S.
    Lefebvre, T.
    Teachey, D. T.
    Anurathapan, U.
    Ho, P. J.
    von Kalle, C.
    Kletzel, M.
    Vichinsky, E.
    Soni, S.
    Veres, G.
    Negre, O.
    Ross, R. W.
    Davidson, D.
    Petrusich, A.
    Sandler, L.
    Asmal, M.
    Hermine, O.
    De Montalembert, M.
    Hacein-Bey-Abina, S.
    Blanche, S.
    Leboulch, P.
    Cavazzana, M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (16): : 1479 - 1493
  • [27] MRI Survey In Transfusion-Dependent and Non-Transfusion-Dependent MDS Patients
    Pepe, Alessia
    Meloni, Antonella
    Carulli, Giancarlo
    Oliva, Esther Natalie
    Arcioni, Francesco
    Storti, Sergio
    Toia, Patrizia
    Renne, Stefania
    Restaino, Gennaro
    Salvatori, Cristina
    Lombardi, Massimo
    Rizzo, Michele
    BLOOD, 2013, 122 (21)
  • [28] Ocular manifestations in patients with transfusion-dependent β-thalassemia
    Akritidou, F.
    Praidou, A.
    Papamitsou, T.
    Kozobolis, V
    Labiris, G.
    HIPPOKRATIA, 2021, 25 (02) : 79 - 82
  • [29] MRI SURVEY IN TRANSFUSION-DEPENDENT AND NON-TRANSFUSION-DEPENDENT MDS PATIENTS
    Pepe, A.
    Meloni, A.
    Carulli, G.
    Oliva, E. N.
    Arcioni, F.
    Fraticelli, V.
    Toia, P.
    Renne, S.
    Restaino, G.
    Positano, V.
    Rizzo, M.
    HAEMATOLOGICA, 2014, 99 : 90 - 90
  • [30] Epididymal and sex accessory gland secretions in transfusion-dependent beta-thalassemic patients: Evidence of an impaired prostatic function
    Carpino, A
    DeSanctis, V
    Siciliano, L
    Maggiolini, M
    Vivacqua, A
    Pinamonti, A
    Sisci, D
    Ando, S
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (03) : 169 - 174